ロード中...
F112. PRESCRIBING PATHWAYS TO CLOZAPINE CO-THERAPY WITH ANTIPSYCHOTICS: A SURVEY OF TERTIARY CARE PSYCHIATRISTS TREATING SCHIZOPHRENIA WITH CLOZAPINE AND ADDITIONAL ANTIPSYCHOTICS
BACKGROUND: Clozapine remains the medication of choice for schizophrenia not responsive to monotherapy. For the approximately 30% of clozapine refractory patients there is little evidence to guide the clinician. Ineffective clozapine trials appear to lead to combination therapy, although evidence is...
保存先:
| 出版年: | Schizophr Bull |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455462/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz018.524 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|